Harrington Valerie, Lau Lilian, Seddu Kumba, Suez Jotham
W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
mSystems. 2021 Aug 31;6(4):101128msystems0075621. doi: 10.1128/mSystems.00756-21.
The human body is home to a dense and diverse population of bacteria, viruses, and eukaryotes, collectively termed the microbiome. Research on host-microbiome interactions continuously demonstrates the importance of this microbial community to human physiology and its involvement in a myriad of diseases. This, in turn, sparks great interest in developing means for beneficially modulating the microbiome, such as fecal microbiome transplantation and probiotics. However, these interventions show mixed efficacy in clinical trials and raise safety concerns. How these exogenous microorganisms interact with the microbiome might underlie the efficacy and safety of these therapeutics, yet the signaling mechanisms mediating microbe-microbe interactions between human-dwelling commensals are poorly understood. In this commentary, we discuss known and putative mechanisms of interactions between commensals in the gut and how they can be harnessed for improving microbiome-targeting therapeutics and facilitating translation of microbiome research to the clinic.
人体是细菌、病毒和真核生物的密集且多样的群落的宿主,这些微生物统称为微生物组。对宿主 - 微生物组相互作用的研究不断证明这个微生物群落对人类生理学的重要性及其在众多疾病中的作用。这反过来又激发了人们对开发有益调节微生物组的方法的浓厚兴趣,例如粪便微生物组移植和益生菌。然而,这些干预措施在临床试验中显示出参差不齐的疗效,并引发了安全问题。这些外源微生物如何与微生物组相互作用可能是这些疗法疗效和安全性的基础,但介导人类共生菌之间微生物 - 微生物相互作用的信号机制却知之甚少。在这篇评论中,我们讨论了肠道中共生菌之间已知的和推测的相互作用机制,以及如何利用这些机制来改进针对微生物组的疗法,并促进微生物组研究向临床的转化。